Billy Kelleher (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

147. To ask the Minister for Health in view of the cost benefit analysis being carried out by the Health Service Executive regarding the provision of Eculizumab on the community drugs scheme, the supports that are currently being offered to patients with this life threatening illness who are not in receipt of the treatment; if one of these patients goes into organ or multi-organ failure while waiting for this treatment, his plans to respond to this emergency; and if he will make a statement on the matter. [3122/15]

Kathleen Lynch (Cork North Central, Labour)
Link to this: Individually | In context | Oireachtas source

As the HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, and is responsible for service matters this has been referred to the HSE for attention and direct reply to you. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.